Intuitive Surgical (ISRG) Income from Continuing Operations (2009 - 2026)
Intuitive Surgical (ISRG) posted Income from Continuing Operations of $823.2 million for Q2 2026, little changed on a QoQ basis from $826.0 million in Q1 2026, and up 23.94% year-over-year from $664.2 million in Q2 2025.
Analysis
Intuitive Surgical (ISRG) Income from Continuing Operations (2009 - 2026) Analysis & Trends
Intuitive Surgical has reported Income from Continuing Operations for 18 years, with the latest figure at $823.2 million in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 23.94% year-over-year to $823.2 million in Q2 2026; TTM through Jun 2026 was $3.2 billion, a 20.23% increase from a year earlier, with the FY2025 full-year figure at $2.9 billion, up 23.06% from the prior year.
- Income from Continuing Operations was $823.2 million for Q2 2026 at Intuitive Surgical, roughly flat from $826.0 million in the prior quarter.
- The five-year high for Income from Continuing Operations was $826.0 million in Q1 2026, with the low at $313.6 million in Q2 2022.
- Average Income from Continuing Operations over 5 years is $556.9 million, with a median of $559.0 million recorded in 2024.
- The sharpest annual moves came in 2022 and 2023: Income from Continuing Operations slumped 40.04% in 2022, then soared 81.38% in 2023.
- Over 5 years, Income from Continuing Operations stood at $336.7 million in 2022, then jumped by 81.38% to $610.7 million in 2023, then increased by 12.66% to $688.0 million in 2024, then climbed by 16.21% to $799.5 million in 2025, then grew by 2.96% to $823.2 million in 2026.
- The last three Income from Continuing Operations figures came in at $823.2 million (Q2 2026), $826.0 million (Q1 2026), and $799.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 178.01 Bn | 172.41 Bn | 7.27 Bn | 928.00 Mn |
| 2 | Intuitive Surgical | 131.29 Bn | 126.08 Bn | 1.96 Bn | 823.20 Mn |
| 3 | Medtronic | 116.38 Bn | 107.56 Bn | 6.34 Bn | 1.48 Bn |
| 4 | Stryker | 106.01 Bn | 102.53 Bn | 4.50 Bn | 1.28 Bn |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 905.00 Mn |
| 6 | Edwards Lifesciences | 48.89 Bn | 44.64 Bn | 1.35 Bn | 241.40 Mn |
| 7 | Alcon | 32.59 Bn | 31.13 Bn | 1.68 Bn | -92.00 Mn |
| 8 | Dexcom | 31.84 Bn | 29.89 Bn | 830.00 Mn | 249.10 Mn |
| 9 | Steris | 20.61 Bn | 20.13 Bn | 684.20 Mn | 201.00 Mn |
| 10 | Zimmer Biomet Holdings | 18.00 Bn | 17.59 Bn | 1.54 Bn | 199.60 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 823.20 Mn |
| Mar 31, 2026 | 826.00 Mn |
| Dec 31, 2025 | 799.50 Mn |
| Sep 30, 2025 | 709.20 Mn |
| Jun 30, 2025 | 664.20 Mn |
| Mar 31, 2025 | 703.70 Mn |
| Dec 31, 2024 | 688.00 Mn |
| Sep 30, 2024 | 570.60 Mn |
| Jun 30, 2024 | 531.50 Mn |
| Mar 31, 2024 | 547.40 Mn |
| Dec 31, 2023 | 610.70 Mn |
| Sep 30, 2023 | 419.80 Mn |
| Jun 30, 2023 | 426.00 Mn |
| Mar 31, 2023 | 360.80 Mn |
| Dec 31, 2022 | 336.70 Mn |
| Sep 30, 2022 | 324.70 Mn |
| Jun 30, 2022 | 313.60 Mn |
| Mar 31, 2022 | 369.40 Mn |
| Dec 31, 2021 | 382.70 Mn |
| Sep 30, 2021 | 387.20 Mn |